Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

Abstract:

:The blockade of platelet integrin glycoprotein (GP) IIb/IIIa is a promising new antiplatelet strategy. The binding of ligands or of the ligand-mimetic peptide RGD causes a conformational change of GP IIb/IIIa from the nonactivated to the activated state. Because several blocking agents/inhibitors are ligand-mimetics, the current study evaluates whether these agents have the intrinsic property to activate GP IIb/IIIa. Fibrinogen binding to GP IIb/IIIa on platelets or on CHO cells expressing recombinant GP IIb/IIIa was evaluated by flow cytometry or 125I-labeled fibrinogen. Incubation with the monoclonal antibody (MoAb) fragment c7E3 (abciximab) results in fibrinogen binding to GP IIb/IIIa and in the access of ligand-induced binding sites. At low concentrations (0.01 to 0.1 microgram/mL), this intrinsic activating property of c7E3 can result in platelet aggregation. The disintegrin flavorodin and the RGD analogue fradafiban also induce fibrinogen binding, whereas the blocking MoAbs 2G12 and P2 and the activation-specific MoAb PAC-1 do not. Aspirin and indomethacin cannot block c7E3-induced fibrinogen binding to GP IIb/IIIa, but can inhibit c7E3-induced platelet aggregation. Thus, we conclude that GP IIb/IIIa inhibitors can demonstrate an intrinsic activating property, which can result in fibrinogen binding to GP IIb/IIIa and consequently in platelet aggregation. Cyclooxygenase inhibitors can inhibit platelet aggregation caused by GP IIb/IIIa inhibitors. Further studies will have to evaluate the clinical relevance of the potential intrinsic activating property of GP IIb/IIIa inhibitors and define consequences for the future drug development and evaluation of these potent antiplatelet agents.

journal_name

Blood

journal_title

Blood

authors

Peter K,Schwarz M,Ylänne J,Kohler B,Moser M,Nordt T,Salbach P,Kübler W,Bode C

subject

Has Abstract

pub_date

1998-11-01 00:00:00

pages

3240-9

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

92

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Smad7 promotes self-renewal of hematopoietic stem cells.

    abstract::The Smad-signaling pathway downstream of the transforming growth factor-beta superfamily of ligands is an evolutionarily conserved signaling circuitry with critical functions in a wide variety of biologic processes. To investigate the role of this pathway in the regulation of hematopoietic stem cells (HSCs), we have b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-005611

    authors: Blank U,Karlsson G,Moody JL,Utsugisawa T,Magnusson M,Singbrant S,Larsson J,Karlsson S

    更新日期:2006-12-15 00:00:00

  • Age-dependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit.

    abstract::The white-spotting (Ws) locus of rats represents a 12-base deletion of the c-kit receptor tyrosine kinase. Homozygous Ws/Ws rats are deficient in melanocytes, mast cells, and erythrocytes. Although mice possessing two mutant alleles at the c-kit (W) locus, such as mice of W/Wv genotype, show severe anemia even in adul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morimoto M,Kasugai T,Tei H,Jippo-Kanemoto T,Kanakura Y,Kitamura Y

    更新日期:1993-12-01 00:00:00

  • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.

    abstract::We aimed to determine the prognostic impact of monosomal karyotype (MK) in acute myeloid leukemia (AML) in the context of the current World Health Organization (WHO) classification and to evaluate the outcome of MK(+) patients after allogeneic HSCT. Of 1058 patients with abnormal cytogenetics, 319 (30%) were MK MK(+)....

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-07-367508

    authors: Kayser S,Zucknick M,Döhner K,Krauter J,Köhne CH,Horst HA,Held G,von Lilienfeld-Toal M,Wilhelm S,Rummel M,Germing U,Götze K,Nachbaur D,Schlegelberger B,Göhring G,Späth D,Morlok C,Teleanu V,Ganser A,Döhner H,Schlenk

    更新日期:2012-01-12 00:00:00

  • Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.

    abstract::Low concentrations of As(2)O(3) (

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jing Y,Dai J,Chalmers-Redman RM,Tatton WG,Waxman S

    更新日期:1999-09-15 00:00:00

  • CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes.

    abstract::Evidence is presented showing that a protein tyrosine phosphatase different from CD45 is present on the membrane of human hematopoietic cells. The molecule recognized by the monoclonal antibody 143-41, which has been classified as CD148 in the VI International Workshop on Leukocyte Differentiation Antigens, was immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de la Fuente-García MA,Nicolás JM,Freed JH,Palou E,Thomas AP,Vilella R,Vives J,Gayá A

    更新日期:1998-04-15 00:00:00

  • Malaria selectively targets pregnancy receptors.

    abstract::In this issue of Blood, Rieger et al show that malaria parasite infiltration in the human placenta requires a specific geometry and affinity of host receptors to facilitate strong adhesion. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-11-610634

    authors: Chishti AH

    更新日期:2015-01-08 00:00:00

  • Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

    abstract::Globally suppressed T-cell function has been described in many patients with cancer to be a major hurdle for the development of clinically efficient cancer immunotherapy. Inhibition of antitumor immune responses has been mainly linked to inhibitory factors present in cancer patients. More recently, increased frequenci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0642

    authors: Beyer M,Kochanek M,Darabi K,Popov A,Jensen M,Endl E,Knolle PA,Thomas RK,von Bergwelt-Baildon M,Debey S,Hallek M,Schultze JL

    更新日期:2005-09-15 00:00:00

  • cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2.

    abstract::The large multimeric glyocoprotein von Willebrand factor (VWF) is a crucial component of both primary and secondary hemostasis. It is stored in secretory granules of vascular endothelial cells, the Weibel-Palade bodies (WPBs), and is released following stimulation by agonists that raise intracellular Ca(2+) or cyclic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475251

    authors: Brandherm I,Disse J,Zeuschner D,Gerke V

    更新日期:2013-08-08 00:00:00

  • Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

    abstract::The therapeutic potential of hematopoietic stem cell (HSC) gene therapy can be fully exploited only by reaching efficient gene transfer into HSCs without compromising their biologic properties. Although HSCs can be transduced by HIV-derived lentiviral vectors (LVs) in short ex vivo culture, they display low permissivi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4047

    authors: Santoni de Sio FR,Cascio P,Zingale A,Gasparini M,Naldini L

    更新日期:2006-06-01 00:00:00

  • Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

    abstract::Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected f...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-378943

    authors: Pui CH,Mullighan CG,Evans WE,Relling MV

    更新日期:2012-08-09 00:00:00

  • Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance.

    abstract::The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance between the activity of the donor immune system against malignant and nonmalignant cells of the recipient. Abrogation of alloreactivity will lead to disease relapse, whereas untamed allo-immune responses will lead to l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000951

    authors: Voermans C,Hazenberg MD

    更新日期:2020-07-23 00:00:00

  • Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses.

    abstract::Fifty patients with Philadelphia chromosome-positive (Ph(+)) chronic myelogenous leukemia (CML) in early chronic phase received imatinib mesylate, 400 mg orally daily. After a median follow-up of 9 months, 49 patients (98%) achieved a complete hematologic response and 45 patients (90%) achieved a major cytogenetic res...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-02-0545

    authors: Kantarjian HM,Cortes JE,O'Brien S,Giles F,Garcia-Manero G,Faderl S,Thomas D,Jeha S,Rios MB,Letvak L,Bochinski K,Arlinghaus R,Talpaz M

    更新日期:2003-01-01 00:00:00

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM) is an antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma (MM). We initiated a phase 1 clinical trial vaccinating 10 patients with R3 (ILSLELMKL), a hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-099366

    authors: Schmitt M,Schmitt A,Rojewski MT,Chen J,Giannopoulos K,Fei F,Yu Y,Götz M,Heyduk M,Ritter G,Speiser DE,Gnjatic S,Guillaume P,Ringhoffer M,Schlenk RF,Liebisch P,Bunjes D,Shiku H,Dohner H,Greiner J

    更新日期:2008-02-01 00:00:00

  • Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.

    abstract::Dense, dehydrated red blood cells (DRBCs) are a characteristic feature of sickle-cell disease (SCD). DRBCs play a role in the pathophysiology of SCD acute and chronic organ damage because of heightened tendency to undergo polymerization and sickling because of their higher hemoglobin S concentration. Relations between...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-424184

    authors: Bartolucci P,Brugnara C,Teixeira-Pinto A,Pissard S,Moradkhani K,Jouault H,Galacteros F

    更新日期:2012-10-11 00:00:00

  • Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.

    abstract::Donor lymphocyte infusion (DLI) can restore durable molecular remission in a high percentage of patients with chronic myeloid leukemia (CML) who have relapses after allogeneic stem cell transplantation, but for patients who do not respond survival is poor. Imatinib mesylate (STI571) is a specific inhibitor of BCR-ABL ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3861

    authors: Olavarria E,Craddock C,Dazzi F,Marin D,Marktel S,Apperley JF,Goldman JM

    更新日期:2002-05-15 00:00:00

  • The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

    abstract::D assemblies make up half of the von Willebrand factor (VWF), yet are of unknown structure. D1 and D2 in the prodomain and D'D3 in mature VWF at Golgi pH form helical VWF tubules in Weibel Palade bodies and template dimerization of D3 through disulfides to form ultralong VWF concatemers. D'D3 forms the binding site fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-876300

    authors: Dong X,Leksa NC,Chhabra ES,Arndt JW,Lu Q,Knockenhauer KE,Peters RT,Springer TA

    更新日期:2019-04-04 00:00:00

  • Evidence that growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells.

    abstract::Donor-matched transplantation of hematopoietic stem cells (HSCs) is widely used to treat hematologic malignancies but is associated with high mortality. The expansion of HSC numbers and their mobilization into the bloodstream could significantly improve therapy. We report here that adult mice conditionally deficient f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-280305

    authors: Khandanpour C,Sharif-Askari E,Vassen L,Gaudreau MC,Zhu J,Paul WE,Okayama T,Kosan C,Möröy T

    更新日期:2010-12-09 00:00:00

  • Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

    abstract::CD8(+) T cell-numbers rapidly expand and then contract after exposure to their cognate antigen. Here we show that the sustained frequencies of transgene product-specific CD8(+) T cells elicited by replication-defective adenovirus vectors are linked to persistence of low levels of transcriptionally active adenovirus ve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-062117

    authors: Tatsis N,Fitzgerald JC,Reyes-Sandoval A,Harris-McCoy KC,Hensley SE,Zhou D,Lin SW,Bian A,Xiang ZQ,Iparraguirre A,Lopez-Camacho C,Wherry EJ,Ertl HC

    更新日期:2007-09-15 00:00:00

  • Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5.

    abstract::We used synthetic peptides to the extracellular loops (ECLs) of CCR5 to examine inhibitory effects on HIV infection/fusion with primary leukocytes and cells expressing recombinant CCR5. We show for the first time that peptides derived from the first, second, or third ECL caused dose-dependent inhibition of fusion and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2669

    authors: Agrawal L,VanHorn-Ali Z,Berger EA,Alkhatib G

    更新日期:2004-02-15 00:00:00

  • TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.

    abstract::Large granular lymphocyte (LGL) leukemia results from clonal expansion of CD3+ cytotoxic T lymphocytes or CD3- natural killer (NK) cells. Chronic antigen stimulation is postulated to promote long-term survival of LGL leukemia cells through constitutive activation of multiple survival pathways, resulting in global dysr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-09-808816

    authors: Yang J,LeBlanc FR,Dighe SA,Hamele CE,Olson TL,Feith DJ,Loughran TP Jr

    更新日期:2018-06-21 00:00:00

  • Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.

    abstract::Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1 rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non-nodal MCL (nnMCL), that differ in their clinicobiological behavior. To identify the genetic and epigenetic alterations determining this diversity, we used w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005289

    authors: Nadeu F,Martin-Garcia D,Clot G,Díaz-Navarro A,Duran-Ferrer M,Navarro A,Vilarrasa-Blasi R,Kulis M,Royo R,Gutiérrez-Abril J,Valdés-Mas R,López C,Chapaprieta V,Puiggros M,Castellano G,Costa D,Aymerich M,Jares P,Espinet B

    更新日期:2020-09-17 00:00:00

  • MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.

    abstract::Measurements of hepatic iron concentration (HIC) are important predictors of transfusional iron burden and long-term outcome in patients with transfusion-dependent anemias. The goal of this work was to develop a readily available, noninvasive method for clinical HIC measurement. The relaxation rates R2 (1/T2) and R2* ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3982

    authors: Wood JC,Enriquez C,Ghugre N,Tyzka JM,Carson S,Nelson MD,Coates TD

    更新日期:2005-08-15 00:00:00

  • Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

    abstract::In patients with common variable immunodeficiency (CVI), we have previously defined a subgroup of patients (CVIHyper) characterized by decreased numbers of CD4+ lymphocytes in peripheral blood, splenomegaly, and persistent immune activation in vivo, particularly of monocytes/macrophages. To further characterize this h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Aukrust P,Lien E,Kristoffersen AK,Müller F,Haug CJ,Espevik T,Frøland SS

    更新日期:1996-01-15 00:00:00

  • New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.

    abstract::A large number of alterations in genes encoding receptor tyrosine kinase (RTK), namely FLT3, c-KIT, platelet-derived growth factor (PDGF) receptors, fibroblast growth factor (FGF) receptors, and the anaplastic large cell lymphoma kinase (ALK), have been found in hematopoietic malignancies. They have drawn much attenti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-04-279752

    authors: Toffalini F,Demoulin JB

    更新日期:2010-10-07 00:00:00

  • Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) and polycythemia vera (PV) are characterized by persistent platelet activation. The mechanisms involved in their clearance are poorly characterized. In the present study, we report that leukocytes were actively involved in platelet disposal in 51 patients with ET and 30 with PV, but not ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337337

    authors: Maugeri N,Malato S,Femia EA,Pugliano M,Campana L,Lunghi F,Rovere-Querini P,Lussana F,Podda G,Cattaneo M,Ciceri F,Manfredi AA

    更新日期:2011-09-22 00:00:00

  • Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils.

    abstract::Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McDonald PP,Bald A,Cassatella MA

    更新日期:1997-05-01 00:00:00

  • Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans.

    abstract::We have previously reported that continuous intravenous (IV) administration of recombinant granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) to humans following high-dose alkylating agent chemotherapy and autologous bone marrow support (ABMS) results in myeloid bone marrow maturation, accelerated granulocyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peters WP,Stuart A,Affronti ML,Kim CS,Coleman RE

    更新日期:1988-10-01 00:00:00

  • Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors.

    abstract::The effects of human recombinant erythropoietin (rEpo) in the presence of other stimulators on the growth of clonogenic leukemic blast cells from ten Japanese patients with acute myeloblastic leukemia were studied with an in vitro leukemic blast colony assay in methylcellulose culture. With the addition of rEpo alone,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Asano Y,Okamura S,Shibuya T,Harada M,Niho Y

    更新日期:1988-11-01 00:00:00

  • Selective suppression of IL-12 production by human herpesvirus 6.

    abstract::Human herpesvirus 6 (HHV-6) is a potentially immunosuppressive agent that has been suggested to act as a cofactor in the progression of HIV disease. Exposure of human macrophages to HHV-6A or HHV-6B profoundly impaired their ability to produce interleukin 12 (IL-12) upon stimulation with interferon-gamma (IFN-gamma) a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3152

    authors: Smith A,Santoro F,Di Lullo G,Dagna L,Verani A,Lusso P

    更新日期:2003-10-15 00:00:00

  • The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.

    abstract::Oncogenic transformation of CD4(+) T cells by human T-cell lymphotropic virus type 1 (HTLV-1) is understood as the initial step to adult T-cell leukemia/lymphoma, a process that is mainly initiated by perturbation of cellular signaling by the viral Tax oncoprotein, a potent transcriptional regulator. In search of nove...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-305805

    authors: Kress AK,Kalmer M,Rowan AG,Grassmann R,Fleckenstein B

    更新日期:2011-03-31 00:00:00